262 related articles for article (PubMed ID: 7929413)
1. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system.
Schultz-Cherry S; Ribeiro S; Gentry L; Murphy-Ullrich JE
J Biol Chem; 1994 Oct; 269(43):26775-82. PubMed ID: 7929413
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism.
Schultz-Cherry S; Murphy-Ullrich JE
J Cell Biol; 1993 Aug; 122(4):923-32. PubMed ID: 8349738
[TBL] [Abstract][Full Text] [Related]
3. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.
Schultz-Cherry S; Lawler J; Murphy-Ullrich JE
J Biol Chem; 1994 Oct; 269(43):26783-8. PubMed ID: 7929414
[TBL] [Abstract][Full Text] [Related]
4. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1.
Schultz-Cherry S; Chen H; Mosher DF; Misenheimer TM; Krutzsch HC; Roberts DD; Murphy-Ullrich JE
J Biol Chem; 1995 Mar; 270(13):7304-10. PubMed ID: 7706271
[TBL] [Abstract][Full Text] [Related]
5. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta.
Ribeiro SM; Poczatek M; Schultz-Cherry S; Villain M; Murphy-Ullrich JE
J Biol Chem; 1999 May; 274(19):13586-93. PubMed ID: 10224129
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta complexes with thrombospondin.
Murphy-Ullrich JE; Schultz-Cherry S; Höök M
Mol Biol Cell; 1992 Feb; 3(2):181-8. PubMed ID: 1550960
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin 1 does not activate transforming growth factor beta1 in a chemically defined system or in smooth-muscle-cell cultures.
Grainger DJ; Frow EK
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):291-8. PubMed ID: 10926856
[TBL] [Abstract][Full Text] [Related]
8. Latent transforming growth factor-beta complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectin-ligand or MG-160.
Olofsson A; Hellman U; Ten Dijke P; Grimsby S; Ichijo H; Morén A; Miyazono K; Heldin CH
Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):427-34. PubMed ID: 9182700
[TBL] [Abstract][Full Text] [Related]
9. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology.
Murphy-Ullrich JE; Poczatek M
Cytokine Growth Factor Rev; 2000; 11(1-2):59-69. PubMed ID: 10708953
[TBL] [Abstract][Full Text] [Related]
10. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36.
Yehualaeshet T; O'Connor R; Green-Johnson J; Mai S; Silverstein R; Murphy-Ullrich JE; Khalil N
Am J Pathol; 1999 Sep; 155(3):841-51. PubMed ID: 10487979
[TBL] [Abstract][Full Text] [Related]
11. Activation of platelet-transforming growth factor beta-1 in the absence of thrombospondin-1.
Abdelouahed M; Ludlow A; Brunner G; Lawler J
J Biol Chem; 2000 Jun; 275(24):17933-6. PubMed ID: 10849431
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondins selectively activate one of the two latent forms of transforming growth factor-beta present in adrenocortical cell-conditioned medium.
Souchelnitskiy S; Chambaz EM; Feige JJ
Endocrinology; 1995 Nov; 136(11):5118-26. PubMed ID: 7588249
[TBL] [Abstract][Full Text] [Related]
13. Heparin-binding vitronectin up-regulates latent TGF-beta production by bovine aortic endothelial cells.
Ribeiro SM; Schultz-Cherry S; Murphy-Ullrich JE
J Cell Sci; 1995 Apr; 108 ( Pt 4)():1553-61. PubMed ID: 7542256
[TBL] [Abstract][Full Text] [Related]
14. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
[TBL] [Abstract][Full Text] [Related]
15. Augmented binding and activation of latent transforming growth factor-beta by a tryptic fragment of latency associated peptide.
Abe M; Oda N; Sato Y; Shibata K; Yamasaki M
Endothelium; 2002; 9(1):25-36. PubMed ID: 12901358
[TBL] [Abstract][Full Text] [Related]
16. Specific interaction of oxidized low-density lipoprotein with thrombospondin-1 inhibits transforming growth factor-beta from its activation.
Sakamoto Y; Miyazaki A; Tamagawa H; Wang GP; Horiuchi S
Atherosclerosis; 2005 Nov; 183(1):85-93. PubMed ID: 15907858
[TBL] [Abstract][Full Text] [Related]
17. Cell-associated activation of latent transforming growth factor-beta by calpain.
Abe M; Oda N; Sato Y
J Cell Physiol; 1998 Feb; 174(2):186-93. PubMed ID: 9428805
[TBL] [Abstract][Full Text] [Related]
18. Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1.
Poczatek MH; Hugo C; Darley-Usmar V; Murphy-Ullrich JE
Am J Pathol; 2000 Oct; 157(4):1353-63. PubMed ID: 11021838
[TBL] [Abstract][Full Text] [Related]
19. Identification of a transforming growth factor beta-1 activator derived from a human gastric cancer cell line.
Horimoto M; Kato J; Takimoto R; Terui T; Mogi Y; Niitsu Y
Br J Cancer; 1995 Sep; 72(3):676-82. PubMed ID: 7669580
[TBL] [Abstract][Full Text] [Related]
20. Autocrine thrombospondin partially mediates TGF-beta1- induced proliferation of vascular smooth muscle cells.
Sajid M; Lele M; Stouffer GA
Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2159-65. PubMed ID: 11045949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
